FDA OKs First Treatment for Chronic Rhinosinusitis With Polyps FDA OKs First Treatment for Chronic Rhinosinusitis With Polyps

Dupilumab is the first treatment approved for inadequately controlled chronic rhinosinusitis with nasal polyps.FDA Approvals
Source: Medscape Med Students Headlines - Category: Universities & Medical Training Tags: Allergy & Clinical Immunology News Alert Source Type: news